Perspective
Published on 01 Oct 2021
Revisiting Secondary Information Related to Pharmacogenetic Testing
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.741395
- 3,409 views
- 9 citations
Type at least 3 characters
173 articles
Articles
Brief Research Report
Published on 28 Sep 2021
Clinical Implications of Combinatorial Pharmacogenomic Tests Based on Cytochrome P450 Variant Selection
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.719671
- 4,920 views
- 10 citations
Mini Review
Published on 22 Sep 2021
What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.740216
- 14,738 views
- 44 citations
Original Research
Published on 20 Sep 2021
Single Nucleotide Polymorphisms in Apolipoprotein B, Apolipoprotein E, and Methylenetetrahydrofolate Reductase Are Associated With Serum Lipid Levels in Northern Chilean Subjects. A Pilot Study
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.640956
- 2,706 views
- 5 citations
Editorial
Published on 05 Aug 2021
Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.736626
- 2,644 views
- 1 citation
Original Research
Published on 03 Aug 2021
Pharmacogenomics Guided Prescription Changes Improved Medication Effectiveness in Patients With Mental Health-Related Disability: A Retrospective Cohort Analyses
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.644694
- 3,062 views
- 3 citations
Systematic Review
Published on 30 Jul 2021
An Analysis of Pharmacogenomic-Guided Pathways and Their Effect on Medication Changes and Hospital Admissions: A Systematic Review and Meta-Analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.698148
- 10,774 views
- 23 citations
Review
Published on 12 Jul 2021
CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations—Implication for Drug Safety, Dosing, and Individualized Therapy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.692234
- 25,447 views
- 52 citations
Mini Review
Published on 08 Jul 2021
CYP3A4∗22 Genotyping in Clinical Practice: Ready for Implementation?
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.711943
- 14,040 views
- 47 citations
Review
Published on 25 Jun 2021
Pharmacogenomics of Hypersensitivity to Non-steroidal Anti-inflammatory Drugs
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.647257
- 9,380 views
- 11 citations
Original Research
Published on 23 Jun 2021
Polymorphism in INSR Locus Modifies Risk of Atrial Fibrillation in Patients on Thyroid Hormone Replacement Therapy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.652878
- 2,491 views
- 1 citation
Methods
Published on 17 Jun 2021
Visual Genomics Analysis Studio as a Tool to Analyze Multiomic Data
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.642012
- 7,787 views
- 15 citations
Original Research
Published on 15 Jun 2021
Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.662734
- 3,174 views
- 13 citations
Systematic Review
Published on 14 Jun 2021
The Genetics of Adverse Drug Outcomes in Type 2 Diabetes: A Systematic Review
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.675053
- 7,166 views
- 9 citations
Mini Review
Published on 16 Apr 2021
Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.641905
- 7,385 views
- 18 citations
Original Research
Published on 09 Apr 2021
G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2021.645688
- 4,509 views
- 2 citations